Search Results - "Gordon, Gilad S."

Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study by Sirivichayakul, Chukiat, Barranco-Santana, Elizabeth A., Esquilin-Rivera, Inés, Oh, Helen M. L., Raanan, Marsha, Sariol, Carlos A., Shek, Lynette P., Simasathien, Sriluck, Smith, Mary Kathryn, Velez, Ivan Dario, Wallace, Derek, Gordon, Gilad S., Stinchcomb, Dan T.

“…Background. A safe, effective tetravalent dengue vaccine is a global health priority. The safety and immunogenicity of a live attenuated, recombinant…”
Get full text

Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study by Osorio, Jorge E, Dr Prof, Velez, Ivan D, PhD, Thomson, Cynthia, PhD, Lopez, Liliana, BACT, Jimenez, Alejandra, MD, Haller, Aurelia A, PhD, Silengo, Shawn, BS, Scott, Jaclyn, PhD, Boroughs, Karen L, MS, Stovall, Janae L, MS, Luy, Betty E, MS, Arguello, John, MS, Beatty, Mark E, MD, Santangelo, Joseph, PhD, Gordon, Gilad S, MD, Huang, Claire Y-H, PhD, Stinchcomb, Dan T, PhD

“…Summary Background Dengue virus is the most serious mosquito-borne viral threat to public health and no vaccines or antiviral therapies are approved for dengue…”
Get full text

Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study by Rupp, Richard, Luckasen, Gary Joseph, Kirstein, Judith Lee, Osorio, Jorge E, Santangelo, Joseph D, Raanan, Marsha, Smith, Mary Kathryn, Wallace, Derek, Gordon, Gilad S, Stinchcomb, Dan T

“…Highlights • A tetravalent dengue vaccine (TDV) was evaluated in a Phase 1b clinical trial. • The different dose schedules and formulations of TDV were well…”
Get full text

An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A phase I, double blind, randomized, placebo-controlled, study of two dosages by Tambyah, Paul A., Oon, Jolene, Asli, Rosmonaliza, Kristanto, William, Hwa, Shi-Hsia, Vang, Fue, Karwal, Lovkesh, Fuchs, Jeremy, Santangelo, Joseph D., Gordon, Gilad S., Thomson, Cynthia, Rao, Raman, Dean, Hansi, Das, Subash C., Stinchcomb, Dan T.

“…•Enteroviruses increasingly noted as causing severe disease, especially in children.•Phase I clinical trial of inactivated B2 sub-genotype EV71 vaccine…”
Get full text

An open‐label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer by Morrow, Phuong Khanh, Murthy, Rashmi K., Ensor, Joe D., Gordon, Gilad S., Margolin, Kim A., Elias, Anthony D., Urba, Walter J., Weng, David E., Rugo, Hope S., Hortobagyi, Gabriel N.

“…BACKGROUND: Serum and plasma levels of vascular endothelial growth factor (VEGF) correlate with prognosis in patients with metastatic breast cancer (MBC). VEGF…”
Get full text

Costs, effects and C/E-ratios alongside a clinical trial by van Hout, B A, Al, M J, Gordon, G S, Rutten, F F

“…A general approach is discussed to assess the uncertainty surrounding the cost effectiveness ratio (C/E-ratio) estimated on the basis of data from a randomised…”
Get more information

Phase 1 Trial of Cobomarsen, an Inhibitor of Mir-155, in Cutaneous T Cell Lymphoma by Querfeld, Christiane, Foss, Francine M., Kim, Youn H., Pinter-Brown, Lauren, William, Basem M., Porcu, Pierluigi, Pacheco, Theresa, Haverkos, Bradley M., DeSimone, Jennifer, Guitart, Joan, Halwani, Ahmad S, Eradat, Herbert A., Huen, Auris, Schroeder, Kristin, Pestano, Linda A., Williams, Paul J., Cheronis, Ioanna, Gordon, Gilad S., Escolar, Diana, Rubin, Paul, Marshall, William S.

“…Background: Cobomarsen (MRG-106) is an inhibitor of miR-155, a microRNA with a strong link to cutaneous T cell lymphoma (CTCL) pathogenesis. The goals of this…”
Get full text

Results from the Phase I Portion of a Phase I/II Study of ATN-224 and Bortezomib for Patients with Multiple Myeloma Relapsed from or Refractory to Bortezomib by Berenson, James R., Ervin, Thomas, Boccia, Ralph V., Batuman, Olcay, Swift, Regina, Abaya, Christina DiLauro, Mazar, Andrew P., Gordon, Gilad S., Reich, Steven D., Callahan, Jennifer A.

“…ATN-224 (bis-choline tetrathiomolybdate) is an orally-available small molecule that is currently being studied in several phase II oncology clinical trials…”
Get full text

Hospital Drug Formularies and Use of Hospital Services by Sloan, Frank A., Gordon, Gilad S., Cocks, Douglas L.

“…Many hospitals have introduced formularies to reduce hospital pharmacy expense, among other reasons. This study provides empirical evidence on the influence of…”
Get full text

Insulin administered intranasally as an insulin-bile salt aerosol. Effectiveness and reproducibility in normal and diabetic subjects by Moses, A C, Gordon, G S, Carey, M C, Flier, J S

“…Efficacy and reproducibility of insulin administered intranasally as an insulin-deoxycholate 1% (w/v) aerosol to normal and diabetic subjects were assessed by…”
Get full text

Lack of effectiveness of intranasal administration of human factor VIII by Gordon, G S, Hathaway, W E, Robinson, W A

Get more information

Intranasal administration of deferoxamine to iron overloaded patients by Gordon, G S, Ambruso, D R, Robinson, W A, Githens, J H

“…We examined the effect of intranasal administration of deferoxamine on iron excretion in seven patients with iron overload secondary to chronic transfusion…”
Get more information

Charges for comprehensive obstetric care at teaching and nonteaching hospitals. A comparison by Gordon, G. S., Sefcik, S. E., Lo Gerfo, J. P.

“…We compared total charges for obstetric care at a major teaching hospital and faculty group practice with those at 3 nonteaching centers in western Washington…”
Get full text